Therapeutic potential of Na-H exchange inhibitors for the treatment of heart failure

By Karmazyn M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 835-843

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy

By Movsesian Matthew A   Alharethi Rami  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1529-1536

Informa Healthcare

Access to resources Recommend Favorite

The potential therapeutic use of phosphodiesterase 10 inhibitors

By Kehler Jan   Ritzén Andreas   Greve Daniel Rodriguez  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 2, 2007-02 ,pp. : 147-158

Informa Healthcare

Access to resources Recommend Favorite

Cyclic Nucleotide Phosphodiesterase in Human Bronchial Epithelial Cells: Characterization of Isoenzymes and Functional Effects of PDE Inhibitors

By dent G.   White S.R.   Tenor H.   Bodtke K.   Schudt C.   Leff A.R.   Magnussen H.   Rabe K.F.  

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 1, 1998-02 ,pp. : 47-56

Academic Press

Access to resources Recommend Favorite

Therapeutic Potential of Ghrelin in the Treatment of Heart Failure

By Nagaya Noritoshi   Kangawa Kenji  

Drugs, Vol. 66, Iss. 4, 2006-01 ,pp. : 439-448

Adis International

Access to resources Recommend Favorite